Covestor’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Other funds holding BMRN
Covestor's BMRN Position: Q3 2026 in Review
Covestor reduced its BioMarin Pharmaceuticals (BMRN) stake by 42% in Q3 2026, selling an estimated $32K and leaving 709 shares worth $43K. The position accounts for 0.03% of the portfolio, ranked #808.
Covestor first reported a position in BMRN in Q4 2021 and has held it in 20 quarters since. The position peaked at $338K in Q4 2025. 249 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.
- Covestor held 709 shares of BioMarin Pharmaceuticals worth $43K as of Q3 2026.
- Covestor sold 508 BioMarin Pharmaceuticals shares in Q3 2026, an estimated $32K.
- BioMarin Pharmaceuticals made up 0.03% of Covestor's portfolio in Q3 2026, its #808 holding.
- Covestor first reported a position in BioMarin Pharmaceuticals in Q4 2021 and has held it in 20 quarters since.
- Covestor's BioMarin Pharmaceuticals position peaked at $338K in Q4 2025.
- 249 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.